white house glp-1 Administration announces deal to lower prices Medical Weight Loss in Whitehouse,

Newer therapies are being developed because the biology of weight regulation is complex

Retatrutide should be considered a second-line or specialized first-line agent for complex cases once it gains regulatory approval

doi: 10.1016/j.jand.2024.10.023

A further drive to utilise GLP-1 RAs arises from the cardiorenal benefits offered with some of the therapies

Sukumar J., Raghavendra A., Pasyar S., et al., Retrospective Study of GLP1 Receptor Agonists in Breast Cancer Survivors: Weight Loss and Patient Outcomes, Presented at the San Antonio Breast Cancer Symposium (SABCS), December 1013, 2024

Patients should reach out if they experience persistent nausea, vomiting, or diarrhea that prevents adequate nutrition or hydration (which may lead to dehydration and kidney problems)